Bio-Techne TECH CapEx
CapEx at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Techne's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Techne's capex?
- Bio-Techne (TECH) reported capex of $9.09M in Q1 2026.
- How has Bio-Techne's capex changed year-over-year?
- Bio-Techne's capex decreased by 10.2% year-over-year, from $10.12M to $9.09M.
- What is the long-term trend for Bio-Techne's capex?
- Over 4 years (2021 to 2025), Bio-Techne's capex has grown at a -8.5% compound annual growth rate (CAGR), from $44.3M to $31.01M.
- What does capex mean?
- Cash spent on physical assets like buildings and equipment.
- How do you interpret capex?
- Higher spending signals growth investment and capacity expansion, while lower spending may indicate a focus on cash flow optimization or asset maturity.
- How does capex compare across companies?
- High in manufacturing-heavy life sciences companies requiring specialized R&D and production facilities.